Overview A Trial of SHR0302Base in Patients With Vitiligo Status: RECRUITING Trial end date: 2026-04-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the efficacy and safety of SHR0302Base in participants with nonsegmental vitiligo.Phase: PHASE2 Details Lead Sponsor: Jiangsu HengRui Medicine Co., Ltd.